<DOC>
	<DOCNO>NCT01876316</DOCNO>
	<brief_summary>The Effect Ethnic Moxifloxacin Induced QT Interval Prolongation Korean Japanese Healthy Subjects</brief_summary>
	<brief_title>The Effect Ethnic Moxifloxacin Induced QT Interval Prolongation Korean Japanese Healthy Subjects</brief_title>
	<detailed_description>The purpose study explore ethnic gender difference Moxifloxacin induce QT interval prolongation Japanese Korean subject .</detailed_description>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>1 ) Subjects Japan Korea deem healthy determine clinically significant deviation normal medical history , physical examination , ECGs , clinical laboratory determination . 2 ) Body Mass Index ( BMI ) 17.6 26.4 kg/m2 , BMI = weight ( kg ) / [ height ( ) ] 2 . 1 ) Evidence organ dysfunction clinically significant deviation normal physical examination , vital sign , ECG clinical laboratory determination beyond consistent target population . 2 ) Any follow 12lead ECG prior study drug administration , confirm repeat . Heart rate ≤ 45 bpmmsec Heart rate ≥ 100 bpmmsec PR ≥ 210 msec QRS ≥ 120 msec QT ≥ 500 msec QTcF : male ≥ 450 msec , female ≥470msec Iincomplete right bundle branch block Marked Sinus Arrhythmia Wondering pacemaker Atrial rhythm</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Moxifloxacin</keyword>
	<keyword>QT interval prolongation</keyword>
	<keyword>Korean</keyword>
	<keyword>Japanese</keyword>
</DOC>